Compare RJET & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RJET | BVS |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | 8400 | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.0M | 783.2M |
| IPO Year | N/A | 2016 |
| Metric | RJET | BVS |
|---|---|---|
| Price | $21.97 | $13.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 96.6K | ★ 718.9K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $0.21 | $336.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.37 | $6.26 |
| 52 Week High | $26.70 | $14.00 |
| Indicator | RJET | BVS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.17 |
| Support Level | N/A | $8.04 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.53 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 0.00 | 77.09 |
Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.